Effect of soya protein on serum lipid profile and lipoprotein concentrations in patients undergoing hypercholesterolaemic haemodialysis

British Journal of Nutrition

Volumn 95, Issue 2, 2006, Pages 366-371

  Chen, Shu Tzu ^a   Chen, Jiun Rong ^a   Yang, Chwei Shiun ^b   Peng, Sheng Jeng ^b   Feng, Shyang Hwa ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

Haemodialysis; Hypercholesterolaemia; Lipoproteins; Soya protein

Indexed keywords

APOLIPOPROTEIN B; CALCIUM; CARBOHYDRATE; FAT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ISOFLAVONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MILK PROTEIN; P 93; SOYBEAN PROTEIN; SUPRO 660; APOLIPOPROTEIN; CHOLESTEROL; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHEMICAL COMPOSITION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; HEMODIALYSIS; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY FUNCTION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NUTRITIONAL HEALTH; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; BEVERAGE; BLOOD; DIET; METHODOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

GLYCINE MAX;

APOLIPOPROTEINS; BEVERAGES; CHOLESTEROL; DIET; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INSULIN; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; MILK PROTEINS; RENAL DIALYSIS; SOYBEAN PROTEINS; TRIGLYCERIDES;

EID: 33644897863     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1079/BJN20051646     Document Type: Article

References (34)

1. Anderson JW, Johnstone BM & Cook-Newell ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333, 276-282.
2. Ascencio C, Torres N, Isoard-Acosta F, Gomez-Perez FJ, Hernandez-Pando R & Tovar AR (2004) Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr 134, 522-529.
3. Attman PO, Samuelsson O & Alaupovic P (1993) Lipoprotein metabolism and renal failure. Am J Kidney Dis 21, 573-592.
4. Azadbakht L, Shakerhosseini R, Atabak S, Jamshidian M, Mehrabi Y & Esmaill-Zadeh A (2003) Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr 57, 1292-1294.
5. Baum JA, Teng H, Erdman JW Jr, et al. (1998) Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 68, 545-551.
6. Chen ST, Peng SJ & Chen JR (2003) Effects of dietary protein on renal function and lipid metabolism in five-sixths nephrectomized rats. Br J Nutr 89, 491-497.
7. D'Amico G, Gentile MG, Manna G, Fellin G, Ciceri R, Cofano F, Petrinic C, Lavarda F, Perolini S & Porrini M (1992) Effect of vegetarian soy diet on hyperlipidaemia in nephrotic syndrome. Lancet 339, 1131-1134.
8. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E & Wahren J (1981) Insulin resistance in uremia. J Clin Invest 67, 563-568.
9. Fanti P, Sawaya BP, Custer LJ & Fanke AA (1999) Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients. J Am Soc Nephrol 10, 864-871.
10. Gardner CD, Newell KA, Cherin R & Haskell WL (2001) The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am J Clin Nutr 73, 728-735.
11. Gianazza E, Eberini I, Arnoldi A, Wait R & Sirtori CR (2003) A proteomic investigation of isolated soy protein with variable effects in experimental and clinical studies. J Nutr 133, 9-14.
12. Iritani N, Sugimoto T, Fukuda H, Komiya M & Ikeda H (1997) Dietary soybean protein increases insulin receptor gene expression in Wistar fatty rats when dietary polyunsaturated fatty acid level is low. J Nutr 127, 1077-1083.
13. K/DOQI (National Kidney Foundation) (2000) Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35, S1-S140.
14. Koch M, Kutkuhn B, Trenkwalder E, Bach D, Grabensee B, Dieplinger H & Kronenberg F (1997) Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein (a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 8, 1889-1898.
15. Kritchevsky D (1995) Dietary protein, cholesterol and atherosclerosis: a review of the early history. J Nutr 125, 589S-593S.
16. Kronenberg F, Lingenhel A, Neyer U, Lhotta K, Konig P, Auinger M, Wiesholzer M, Andersson H & Dieplinger H (2003) Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients. Kidney Int 63, Suppl 84, S113-S116.
17. Kurowska EM & Carroll KK (1990) Essential amino acids in relation to hypercholesterolemia induced in rabbits by dietary casein. J Nutr 120, 831-836.
18. Kurowska EM, Jordan J, Spence JD, Wetmore S, Piche LA, Radzikowski M, Dandona P & Carroll KK (1997) Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects with hypercholesterolemia. Clin Invest Med 20, 162-170.
19. Levey AS, Beto JA, Coronado BE, et al. (1998) Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32, 853-906.
20. Ma KW, Greene EL & Raij L (1992) Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 19, 505-513.
21. National Cholesterol Education Program (1993) Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 269, 3015-3023.
22. Nishizawa Y, Shoji T, Kakiya R, Tsujimoto Y, Tabata T, Ishimura E, Nakatani T, Miki T & Inaba M (2003) Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease. Kidney Int Suppl S117-S120.
23. Potter SM (1995) Overview of proposed mechanisms of the hypocholesterolemic effect of soy. J Nutr 125, 606S-611S.
24. Potter SM, Bakhit RM, Essex-Sorlie DL, Weingartner KE, Chapman KM, Nelson RA, Prabhudesai M, Savage WD, Nelson AI & Winter LW (1993) Depression of plasma cholesterol in men by consumption of baked products containing soy protein. Am J Clin Nutr 58, 501-506.
25. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF & Erdman JW Jr (1998) Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68, 1375S-1379S.
26. Ramsay LE, Yeo WW & Jackson PR (1991) Dietary reduction of serum cholesterol concentration: time to think again. BMJ 303, 953-957.
27. Sarnak MJ (2003) Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 41, 11-17.
28. Sirtori CR, Pazzucconi F, Colombo L, Battistin P, Bondioli A & Descheemaeker K (1999) Double-blind study of the addition of high-protein soya milk v. cows' milk to the diet of patients with severe hypercholesterolaemia and resistance to or intolerance of statins. Br J Nutr 82, 91-96.
29. Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman JW Jr & Hasler CM (2000) Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 71, 1077-1084.
30. Teixeira SR, Tappenden KA, Carson L, Jones R, Prabhudesai M, Marshall WP & Erdman JW Jr (2004) Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr 134, 1874-1880.
31. Terpstra AH, Harkes L & van der Veen FH (1981) The effect of different proportions of casein in semipurified diets on the concentration of serum cholesterol and the lipoprotein composition in rabbits. Lipids 16, 114-119.
32. Tonstad S, Smerud K & Hoie L (2002) A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 76, 78-84.
33. Zhan S & Ho SC (2005) Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81, 397-408.
34. Zhuo XG, Melby MK & Watanabe S (2004) Soy isoflavones intake lowers serum LDL cholesterol: A metaanalysis of 8 randomized controlled trials in humans. J Nutr 134, 2395-2400.